-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
Etravirine-[d4]
Category | Human immunodeficiency Virus (HIV) |
CAS | 1142095-93-9 |
Description | Etravirine-[d4] is the labelled analogue of Etravirine, which is a drug used for the treatment of HIV and a non-nucleoside reverse transcriptase inhibitor (NNRTI). |
Product Information
Synonyms | Etravirine D4; 4-[[6-Amino-5-bromo-2-[(4-cyanophenyl)amino]-4-pyrimidinyl]oxy]-3,5-dimethyl-benzonitrile-d4; Intelence-d4; R 165335-d4; TMC 125-d4 |
IUPAC Name | 4-[[4-amino-5-bromo-6-(4-cyano-2,6-dimethylphenoxy)pyrimidin-2-yl]amino]-2,3,5,6-tetradeuteriobenzonitrile |
Molecular Weight | 439.30 |
Molecular Formula | C20H11D4BrN6O |
Canonical SMILES | CC1=CC(=CC(=C1OC2=NC(=NC(=C2Br)N)NC3=CC=C(C=C3)C#N)C)C#N |
InChI | InChI=1S/C20H15BrN6O/c1-11-7-14(10-23)8-12(2)17(11)28-19-16(21)18(24)26-20(27-19)25-15-5-3-13(9-22)4-6-15/h3-8H,1-2H3,(H3,24,25,26,27)/i3D,4D,5D,6D |
InChIKey | PYGWGZALEOIKDF-LNFUJOGGSA-N |
Purity | 98% |
Solubility | Soluble in DMSO (Slightly), Methanol (Slightly, Heated, Sonicated) |
Appearance | Off-white Solid |
Application | The labeled form of Etravirine is an inhibitor of HIV reverse transcriptase and could be used in the treatment of HIV infection. |
Shelf Life | As supplied, 2 years from the QC date provided on the Certificate of Analysis, when stored properly |
Storage | Store at -20°C |
Complexity | 609 |
Exact Mass | 438.07418 |
PSA | 120.64000 |
Target | Reverse Transcriptase; HIV |
XLogP3-AA | 4.5 |